Spyre Therapeutics, Inc.

ALPS ADVISORS INC SYRE
Report date
3/31/2022
Quarter
2022 Q1
Filed
5/16/2022
Shares
50,735
Value ($000)
117
Weight
0.0%
2021 Q4 - 2022 Q1 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).